Trade Summary

1 week ago, Opaleye Management Inc., serving as 10% owner Owner at Eton Pharmaceuticals, Inc. (ETON), sold 126,685 shares at $37.64 per share, for a total transaction value of $4,768,637.17. Following this transaction, Opaleye Management Inc. now holds 53,315 shares of ETON.

This sale represents a 70.38% decrease in Opaleye Management Inc.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, July 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 7, 2026 at 6:29 PM ET, 5 days after the trade was made.

Eton Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.